|
Jul 24
|
Sector Update: Health Care Stocks Softer in Afternoon Trading
|
|
Jul 24
|
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
|
|
Jul 24
|
Rocket lays off staff; Abivax capitalizes on immune drug data
|
|
Jul 18
|
RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
|
|
Jul 1
|
RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance
|
|
Jul 1
|
Rocket Pharmaceuticals receives FDA clearance of RP-A701
|
|
Jun 30
|
Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy
|
|
May 28
|
Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow
|
|
May 28
|
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
|
|
May 28
|
William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback
|
|
May 28
|
RCKT Stock Tanks on Patient Death in Danon Disease Study
|
|
May 28
|
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death
|
|
May 27
|
Patient dies in Rocket’s Phase II Danon disease gene therapy trial
|
|
May 27
|
Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies
|
|
May 27
|
CoreWeave, Rocket Pharmaceuticals, SoundHound: Trending Tickers
|
|
May 27
|
Sector Update: Health Care Stocks Rise Premarket Tuesday
|
|
Apr 17
|
High Growth Tech Stocks To Watch In The US April 2025
|
|
Apr 16
|
Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz
|
|
Apr 16
|
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?
|
|
Apr 9
|
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple
|